Michael DiFiore
Stock Analyst at Evercore ISI Group
(0.43)
# 4,214
Out of 5,182 analysts
3
Total ratings
50%
Success rate
-30.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael DiFiore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Initiates: Outperform | $44 | $29.40 | +49.66% | 1 | Mar 12, 2026 | |
| SKYE Skye Bioscience | Initiates: Outperform | $10 | $1.06 | +843.40% | 1 | Aug 15, 2025 | |
| ATRA Atara Biotherapeutics | Downgrades: In-Line | n/a | $4.99 | - | 1 | Nov 9, 2023 |
vTv Therapeutics
Mar 12, 2026
Initiates: Outperform
Price Target: $44
Current: $29.40
Upside: +49.66%
Skye Bioscience
Aug 15, 2025
Initiates: Outperform
Price Target: $10
Current: $1.06
Upside: +843.40%
Atara Biotherapeutics
Nov 9, 2023
Downgrades: In-Line
Price Target: n/a
Current: $4.99
Upside: -